Kytopen
PrivateLast Round
Series B
Apr 7, 2026
Total Funding Raised
$37.5M
Momentum Score
25 /100
Company Overview
Kytopen is a biotechnology company that provides a cell engineering platform for producing healthy and functional cells quickly and efficiently.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kytopen Comps
Public and private peers based on sector, stage, and business model.
Kytopen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 7, 2026 | ||||
| Grant | Aug 13, 2024 | ||||
| Debt | Feb 15, 2024 | ||||
| Series A | Sep 28, 2021 | ||||
| Grant | Jun 15, 2021 | ||||
Grant | Jun 2, 2020 |
Kytopen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series A, Series B, Seed |
| National Institute of Allergy and Infectious Diseases | Grant |
| The Engine | Series A, Series B, Pre Seed, Seed |
| Engine Ventures | Series A, Seed, Series B |
| MassVentures | Grant, Series A, Series B |
| Northpond Ventures | Series B, Series A |
| Alexandria Venture Investments | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Raised Series B round.
- Sep 9, 2025
Partnered with T-CURX and Fraunhofer IZI to engineer cell therapies.
Kytopen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kytopen's valuation, stock price, and market status.
